Be part of the knowledge

Medical News
Icotrokinra Shows Sustained Skin Clearance Through 52 Weeks in Psoriasis
Medical News
Phase 3 Data Highlight Early and Broad Response With Deuruxolitinib
Medical News
Early Inflammatory Signals May Precede Alopecia Areata Diagnosis

Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Cardiology
Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
Cardiology
Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Project Oncology®
ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Project Oncology®
Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
CME/CE
Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors
0.25 credits
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician
The Convergence
"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician

Programs

CME/CE In-Person & Virtual Event
April 13, 2026
Pittsburgh, Pennsylvania
Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
AudioAbstracts
Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
CME/CE
GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?
0.25 credits
Recognizing When to Escalate Therapy in Atopic Dermatitis Care
DermConsult
Recognizing When to Escalate Therapy in Atopic Dermatitis Care
Escalating COPD Care: From Flares to Long-Term Control
Deep Breaths: Updates from CHEST
Escalating COPD Care: From Flares to Long-Term Control
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
CME/CE
Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC
0.25 credits

Clinical Practice

SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Cardiology
SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy
Gaps in Shingles Vaccination: What Clinicians Need to Know
VacciNation
Gaps in Shingles Vaccination: What Clinicians Need to Know
Evolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
Cardiology
Evolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV
Cracking the Code of Obstruction: Unmet Needs in oHCM
NEW EPISODE
MinuteCE®
Cracking the Code of Obstruction: Unmet Needs in oHCM
1.00 program credits
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
Project Oncology®
On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC
"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai
The Convergence
"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai

Doctors Lounge

“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
The Convergence
“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI
Disparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
On the Frontlines of Osteoporosis
Disparities in Osteoporosis Care: Addressing Screening and Treatment Barriers
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
The Convergence
"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris
Messy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Rub Some Dirt In It
Messy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
On the Frontlines of Multiple Sclerosis
Uncovering Disparities in Teleneurology Utilization Post-Pandemic
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies
Clinician's Roundtable
Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies

CME

When ß-Blockers Fall Short in oHCM: Time for a New Approach?
NEW EPISODE
MinuteCE®
When ß-Blockers Fall Short in oHCM: Time for a New Approach?
1.00 program credits
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
CME/CE
Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome
0.25 credits
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
NEW EPISODE
MinuteCE®
Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors
1.00 program credits
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
NEW EPISODE
MinuteCE®
From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans
1.00 program credits
Turning Flares Into Function: Flag Uncontrolled Disease
MinuteCE®
Turning Flares Into Function: Flag Uncontrolled Disease
1.00 program credits
MinuteCE®
Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)
1.00 credits 10 episodes

Industry Feature

Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Medical Industry Feature
Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Medical Industry Feature
Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA
Gene Therapy, the Future of Eye Care?
Medical Industry Feature
Gene Therapy, the Future of Eye Care?
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Medical Industry Feature
Living with Psoriatic Arthritis: A Doctor-Patient Conversation
Breakthrough Technology Improves Concussion Assessment and Player Safety
Medical Industry Feature
Breakthrough Technology Improves Concussion Assessment and Player Safety
Neuroplasticity: A Potential Target for the Treatment of Depression
Medical Industry Feature
Neuroplasticity: A Potential Target for the Treatment of Depression

Icotrokinra Shows Sustained Skin Clearance Through 52 Weeks in Psoriasis

Phase 3 Data Highlight Early and Broad Response With Deuruxolitinib

Early Inflammatory Signals May Precede Alopecia Areata Diagnosis

Popular

Hypertrophic Cardiomyopathy: Overcoming Practical Barriers to Treatment in the Era of Myosin Inhibitors

Hypertrophic Cardiomyopathy: Moving From Monitoring to Action in the Era of Myosin Inhibitors

ESTI Refines Pulmonary Nodule Management in Lung Cancer Screening

Concurrent Atezolizumab Fails to Improve Survival in Limited-Stage SCLC

Navigating Today and Shaping Tomorrow in ISM: Personalized Strategies With Current and Emerging KIT Inhibitors

"We have tools that can think alongside us and free us from a lot of burdens," says Dr. Raja-Elie Abdulnour from NEJM Clinician

Programs

Seeing the Invisible: Radiologic Precision to Enable Early Intervention in Bronchiectasis

Are E-Cigarettes Safer? A Closer Look at Lung Cancer Risk

GDMT Is Working Fine, so Why Add More Therapies for Patients With HFrEF?

Recognizing When to Escalate Therapy in Atopic Dermatitis Care

Escalating COPD Care: From Flares to Long-Term Control

Chairperson’s Perspective: Evidence-Informed Clinical Decision-Making in HER2-Overexpressed and TROP2-Targeted NSCLC

Clinical Practice

SCOUT-HCM: Mavacamten in Adolescents With Symptomatic Obstructive Hypertrophic Cardiomyopathy

Gaps in Shingles Vaccination: What Clinicians Need to Know

Evolocumab in Patients Without Significant Atherosclerosis and With Diabetes: A Cardiology Perspective on VESALIUS-CV

Cracking the Code of Obstruction: Unmet Needs in oHCM

On the Frontline: Empowering IO Therapies for Patients with HER2-Negative G/GEJC

"You don't have to know programming to create solutions," says Dr. Michal Nedoszytko, Creator of PostVisit.ai

Doctors Lounge

“We see 40 million Americans a day using ChatGPT for health and wellness-related questions,” says Kate Rouch from OpenAI

Disparities in Osteoporosis Care: Addressing Screening and Treatment Barriers

"Tom is engaging with all of the patients you aren't seeing today–that's the actual power," says Jean-Claude Saghbini from Lumeris

Messy Labs, Major Breakthroughs: The Happy Accidents That Shaped Modern Medicine

Uncovering Disparities in Teleneurology Utilization Post-Pandemic

Artificial Intelligence in Dermatology: Exploring New Diagnostic Strategies

CME

When ß-Blockers Fall Short in oHCM: Time for a New Approach?

Applying Advances in Practice: Case-Based Look at Selecting Therapy for Cushing Syndrome

Redefining oHCM Care: Efficacy and Safety of Myosin Inhibitors

From Evidence to Action: Integrating Emerging Myosin Inhibitors Into oHCM Treatment Plans

Turning Flares Into Function: Flag Uncontrolled Disease

Treat. Target. Transform: Applying Treat-to-Target Principles in the Management of Generalized Myasthenia Gravis (gMG)

Industry Feature

Agitation in Alzheimer’s Dementia: From Expert Consensus to Clinical Practice

Treating Mild Cognitive Impairment in Alzheimer’s Disease: A Therapy’s 2-Way MOA

Gene Therapy, the Future of Eye Care?

Living with Psoriatic Arthritis: A Doctor-Patient Conversation

Breakthrough Technology Improves Concussion Assessment and Player Safety

Neuroplasticity: A Potential Target for the Treatment of Depression

Title

Share on ReachMD

Program Chapters

Segment Chapters

Playlist:

Recommended

Get a Dose of ReachMD in Your Inbox and Practice Smarter Medicine